AGP Picks
View all

AGP Executive Report

Last update: 6 minutes ago

Newborn Health: Guinea-Bissau’s government says it has not approved a proposed hepatitis B vaccine trial in newborns, despite reports that the study had received ethics approval. Health Minister Quinhin Nantote said research involving children must meet national laws and international ethical standards; the US health department also says the trial is not approved. The study would enroll 14,000 babies, with half not receiving the birth dose until six weeks. Hepatitis B can pass from mother to child during birth, and the WHO recommends vaccination within 24 hours.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
9 hours ago

Stand Up for Science pushes Congress to halt CDC vaccine study in Guinea-Bissau

AGP

fallback image
Oct. 8, 2026

Stand Up for Science blasts CDC plan to revive Guinea-Bissau vaccine study

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
Danish University Approves CDC-Funded Trial That Would Delay Hepatitis B Shots for Half of 14,000 Newborns in Guinea-Bissau

Danish University Approves CDC-Funded Trial That Would Delay Hepatitis B Shots for Half of 14,000 Newborns in Guinea-Bissau

Report Shows How IMF-Imposed Austerity Hurts Poor Countries Already Reeling From Iran War

Report Shows How IMF-Imposed Austerity Hurts Poor Countries Already Reeling From Iran War


fallback image
9 hours ago

Stand Up for Science Launches Petition to Halt CDC Vaccine Study in West Africa

EIN Presswire

fallback image
Oct. 8, 2026

Stand Up for Science Condemns CDC’s Attempts to Restart Controversial Vaccine Study in Guinea-Bissau

EIN Presswire

fallback image
Oct. 12, 2026

Countries locked into IMF austerity programs are also around twice as vulnerable to economic fallout from war against Iran

Oxfam

fallback image
Feb. 22, 2026

Guinea-Bissau Stops Trump-Backed Hepatitis B Vaccine Study

MENAFN

fallback image
Feb. 22, 2026

Guinea-Bissau Stops US-Funded Hepatitis B Vaccine Trial

MENAFN

fallback image
Feb. 25, 2026

STAND UP FOR SCIENCE: CDC-FUNDED HEPATITIS B STUDY IN GUINEA-BISSAU CANCELLED

EIN Presswire

More press releases

Video Stories

YouTube video thumbnail:  Controversial US-Backed Hepatitis B Vaccine Trial to Move Forward in Guinea-Bissau
Play
Controversial US-Backed Hepatitis B Vaccine Trial to Move Forward in Guinea-Bissau
YouTube video thumbnail: Guinea-Bissau Elections in Doubt as Senegal Urges Military to Ease Restrictions
Play
Guinea-Bissau Elections in Doubt as Senegal Urges Military to Ease Restrictions
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail:  African Debt Crisis Deepens Ahead of IMF Economic Outlook Report
Play
African Debt Crisis Deepens Ahead of IMF Economic Outlook Report
YouTube video thumbnail: Peter Obi Defends 2023 Nigeria Election Claim Ahead of 2027 Race
Play
Peter Obi Defends 2023 Nigeria Election Claim Ahead of 2027 Race

Video Title

Sign up for:

Guinea Bissau Health Bulletin

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Guinea Bissau Health Bulletin

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.